If you want to explore further, start here: #BeautySupplements #ConsumerHealth #HealthAndWellness #BeautyIndustry #SupplementIndustry #BeautyFromWithin #Nutraceuticals #CollagenSupplements #BeautyTech #SkincareScience #BeautyInnovation #WellnessInnovation To view or add a comment, sign in Want to see the future of consumer health
Both medications can cause side effects like nausea, vomiting, diarrhea, and constipation
Obesity in inflammatory bowel disease: A marker of less severe disease
Endocrinology 144:51455148 Gier B, Matveyenko AV, Kirakossian D, Dawson D, Dry SM, Butler PC (2012) Chronic GLP-1 receptor activation by exendin-4 induces expansion of pancreatic duct glands in rats and accelerates formation of dysplastic lesions and chronic pancreatitis in the Kras(G12D) mouse model
With an effective oral GLP1 on the horizon, we may be entering the next phase of diabetes care,one that could expand access while reshaping treatment pathways
However, Pfizer has not given up and instead chose to improve the formulation of Danuglipron, changing its dosing from twice a day to once daily
